Shares of Health Care sector company Legend Biotech moved 0.2% today, and are now trading at a price of $60.08. The mid-cap stock's daily volume was 433,804 compared to its average volume of 624,042. The S&P 500 index returned a 0.0% performance.
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. The company is based in Somerset and has 1,700 full time employees. Its market capitalization is $10,951,863,296.
14 analysts are following Legend Biotech and have set target prices ranging from $76.0 to $100.0 per share. On average, they have given the company a rating of buy. At today's prices, LEGN is trading -31.49% away from its average analyst target price of $87.69 per share.
Over the last year, LEGN's share price has increased by 17.0%, which represents a difference of 4.0% when compared to the S&P 500. The stock's 52 week high is $77.32 per share whereas its 52 week low is $42.91.
Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) |
---|---|---|---|
2023 | nan | nan | nan |
2020 | nan | nan | nan |
2019 | 307,682 | nan | 307,682 |
2018 | 307,682 | nan | 307,682 |